A value investing podcast. Antipodes is an active global equities investment manager, with offices in Sydney and London. Hear from the Antipodes team and other external thought leaders as they deliver investment updates and share perspectives on companies, macroeconomic trends and investment opportunities across the globe.
Episodes
Wednesday Feb 07, 2024
Wednesday Feb 07, 2024
In this episode, Alison Savas is joined by Antipodes Chief Investment Officer, Jacob Mitchell.
They discuss key macro and market developments in the fourth quarter of 2023 along with how Antipodes is positioning for the year ahead. Jacob and Alison also provide key insights into the investment case for Oracle Corp (NYSE: ORCL).
Key times:
- Has the Fed pulled off a soft landing? 1:00
- The potential for a deterioration in liquidity & headwinds for US equities at the index level: 6:00
- Antipodes current portfolio positioning: 12:00
- Valuation discipline case study - exiting SAP & holding Oracle*: 16:00
- Stock in focus - Oracle Corp (NYSE: ORCL)*: 20:00
*Stock commentary is illustrative only and should not be viewed as a recommendation to buy, hold, or sell any security.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.